Discover 1,431 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,431
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
for
Graves Disease
Location: Tampa FL, Fort Myers FL, Palm Beach Gardens FL,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 70
Code: NCT07661056
Phase 3, Recruiting
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
for
Non-alcoholic Fatty Liver Disease
Location: Tampa FL, Miami Lakes FL, Houston TX, San Antonio TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70
Code: NCT07358546
Phase 1, Recruiting
New
A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis
for
End Stage Renal Disease on Dialysis, Adult
Location: Tampa FL, Orlando FL
Sponsor: Basilea Pharmaceutica
Sex: All
Age: 18 - 70+
Code: NCT07916181
Phase 1, Recruiting
New
A Study to Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function
for
Participants With Moderate and Severe Renal Impairment and Healthy Participants,
Location: Tampa FL, Orlando FL, Miami FL
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07797322
Phase 1, Recruiting
Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
for
Glomerular Disease, Proteinuria
Location: Tampa FL, Lauderdale Lakes FL, Columbus GA,
Sponsor: Angion Biomedica Corp
Sex: All
Age: 18+
Code: NCT04939116
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
for
Primary Membranous Nephropathy
Location: Tampa FL, Boynton Beach FL, Coral Springs FL,
Sponsor: Cerium Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05696613
Phase 3, Recruiting
A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function
for
Healthy
Location: Tampa FL, Orlando FL, Miami Lakes FL
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT07519135
Phase 1, Recruiting
A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function
for
Healthy Participants
Location: Tampa FL, Orlando FL, Miami Lakes FL, Miami FL
Sponsor: Pfizer
Sex: All
Age: 18 - 70
Code: NCT07231991
Phase 1, Recruiting
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
for
Renal Impairment, Healthy
Location: Tampa FL, Orlando FL, Saint Paul MN, Lake Forest CA
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT07315360
Phase 1, Recruiting
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function
for
Hepatic Impairment, Healthy
Location: Tampa FL, Orlando FL, Lake Forest CA
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT07269301
Phase 1, Recruiting
A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
for
Asthma
Location: Tampa FL, Miami Lakes FL, Miami FL, Houston TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 70+
Code: NCT07782996
Phase 3, Recruiting
A Study of NTX-1472 in Social Anxiety Disorder
for
Social Anxiety Disorder (SAD)
Location: Tampa FL, Jacksonville FL, Memphis TN, Austin TX,
Sponsor: Newleos Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07323784
Phase 2, Recruiting
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Tampa FL, Jacksonville FL, Miami FL, Macon GA,
Sponsor: LEO Pharma
Sex: All
Age: 0 - 11
Code: NCT06311682
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
for
Myasthenia Gravis
Location: Clearwater FL, Maitland FL, Greenville SC, New Bern NC,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07673744
Phase 2, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)